| 摘要 |
The present invention relates to a method of determining whether a subject is at risk of having or developing a basal cell carcinoma, comprising testing for said subject the presence of at least one genetic alteration in the Damaged-DNA binding protein 2(DDB2) gene, wherein the presence of said genetic alteration indicates an increased risk of having or developing basal cell carcinoma. |
